All Articles
Long-term Zoloft Side Effects You Should Know About
Medications

Long-term Zoloft Side Effects You Should Know About

Explore the long-term side effects of Zoloft (sertraline), from emotional blunting to withdrawal challenges and physical health impacts.

June 27, 2025
#
 min read
Written by
Outro Team
Reviewed by
Brandon Goode
Key takeways

Long-term Zoloft use can cause emotional blunting, sexual dysfunction, and weight gain that may persist or worsen over time.

Physical effects include increased risks of bleeding, bone fracture, diabetes, and cognitive changes in extended use.

Withdrawal from Zoloft is highly personalized - symptoms can range from mild and brief to severe and prolonged.

Introduction

Sarah had been taking Zoloft for five years when she first noticed something troubling. The medication had initially helped with her anxiety, but gradually she realized she wasn't feeling much of anything at all. Happy moments with her family felt muted, creative projects no longer sparked joy, and even her favorite activities seemed to lose their appeal. When she mentioned this to friends who had taken antidepressants long-term, she discovered she wasn't alone in experiencing these unexpected changes.

While Zoloft (sertraline) has helped millions of people manage depression and anxiety, understanding its long-term effects becomes crucial for anyone considering extended use or currently taking the medication for years. Research reveals that the profile of Zoloft side effects can change significantly with prolonged use, sometimes in ways that differ markedly from the short-term effects discussed when treatment begins.

This exploration of long-term Zoloft effects draws from recent scientific research and patient experiences to provide a comprehensive understanding of what extended sertraline use may involve. The information presented here is for educational purposes and should complement, not replace, discussions with healthcare providers about individual treatment decisions.

What is Zoloft?

Zoloft (sertraline hydrochloride) is a prescription medication belonging to a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). The FDA has approved Zoloft for treating several conditions including major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.

The medication is available in tablet form (25mg, 50mg, and 100mg) and as an oral solution. What many people don't realize is that the oral solution contains 12% alcohol, which can be important for those who need to avoid alcohol for medical or personal reasons.

Unlike older antidepressant medications, SSRIs like Zoloft were developed to be more targeted in their effects. However, what antidepressants actually do in the brain remains more complex than often portrayed. While commonly described as "correcting chemical imbalances," current research suggests their effects involve multiple mechanisms, and the idea of a simple serotonin deficiency causing depression has never been scientifically proven.

Zoloft is metabolized by the liver and should be used with caution in people with liver problems. The medication requires gradual dose reduction when discontinuing, as stopping abruptly can lead to withdrawal symptoms.

What Happens During Long-Term Zoloft Use

When people first start taking Zoloft, the focus typically centers on initial side effects like nausea, headaches, or sleep changes that often diminish within weeks. However, long-term use presents a different picture entirely. The brain and body gradually adapt to the continuous presence of the medication through complex neurobiological changes that can lead to new challenges over months and years.

Research shows that approximately 50% of people taking antidepressants remain on them for three years or longer. During this extended period, the brain's receptor systems undergo significant adaptations, potentially leading to tolerance effects where the medication becomes less effective, or paradoxical effects where symptoms opposite to the medication's intended purpose may emerge.

Emotional and Psychological Long-Term Effects

Emotional Blunting

One of the most commonly reported long-term effects of Zoloft is emotional blunting, affecting approximately 46% of patients on antidepressants according to survey research. This phenomenon involves a dampening of emotional experiences across the spectrum - not just negative emotions like sadness or anxiety, but positive emotions like joy, excitement, and love as well.

People experiencing emotional blunting often describe feeling "numb," "disconnected," or like they're "going through the motions" of life without fully experiencing it. This can have profound impacts on relationships, creativity, motivation, and overall life satisfaction. The effect appears to be dose-dependent, meaning higher doses of Zoloft may increase the likelihood and severity of emotional blunting.

Importantly, research using healthy volunteers has confirmed that emotional blunting results directly from SSRI medication rather than from underlying depression, as participants with no mental health conditions experienced similar emotional dampening effects when given SSRIs for just three weeks.

Tardive Dysphoria

An emerging concern in long-term antidepressant use is the concept of tardive dysphoria - the development of depression-like symptoms as a direct result of prolonged medication use. This phenomenon, analogous to tardive dyskinesia from antipsychotic medications, may occur due to receptor desensitization and tolerance effects.

Some observational studies suggest that people who use antidepressants long-term may actually have poorer outcomes compared to those who use them short-term or not at all, even when controlling for baseline depression severity. This raises important questions about the long-term effectiveness and potential drawbacks of extended Zoloft use.

Cognitive Effects

Long-term Zoloft use can impact cognitive function in several ways. Meta-analyses examining antidepressants in healthy volunteers found that SSRIs like Zoloft can produce impairments in information processing, memory, hand-eye coordination, concentration, and higher-order thinking functions.

These cognitive effects appear to vary significantly between individuals and may include:

  • Reduced processing speed and reaction time
  • Memory difficulties, particularly with new information
  • Decreased concentration and focus
  • Impaired judgment in some cases

Small studies following people with obsessive-compulsive disorder found that cognitive test scores decreased over consecutive weeks of SSRI treatment, though the long-term consequences of these impairments haven't been thoroughly investigated.

Physical Long-Term Side Effects

Sexual Dysfunction

Sexual side effects represent one of the most persistent and troubling long-term effects of Zoloft use.

While sexual problems are a common side effect during active treatment, with up to 23% of people taking SSRIs experiencing an impact on their sex life, these side effects can continue after coming off Zoloft. .

Post-SSRI Sexual Dysfunction (PSSD) involves persistent sexual dysfunction that continues even after discontinuing the medication. Symptoms can include:

  • Genital numbness or reduced sensation
  • Decreased libido (sex drive)
  • Erectile dysfunction
  • Difficulty reaching orgasm or pleasureless orgasm
  • General emotional and physical numbing beyond sexual function

The condition can occur after varying periods of SSRI exposure and may take months or years to resolve, if it resolves at all. Some people experience brief remissions, suggesting the effects may not always be permanent, but the unpredictable nature and potential persistence make this a significant concern for long-term users.

Weight Gain

While initial Zoloft treatment may cause modest weight changes, long-term use presents more substantial risks. A large observational study following nearly 2 million patient-years found that people taking SSRIs had a 30% increased risk of progressing from normal body weight to overweight or obese over a 10-year period compared to those not taking antidepressants.

The study also found a 30% increased chance of overweight people becoming obese during long-term antidepressant treatment. This weight gain tends to be progressive and may accelerate over time, making it increasingly difficult to manage with standard diet and exercise approaches alone.

Other Physical Effects

Extended Zoloft use is associated with several other physical health risks:

Bleeding and Bone Health: Long-term SSRI use increases risks of bleeding disorders and bone fractures. In older adults, research shows absolute increased risks over one year of SSRI exposure including a 2.2% increased risk of falls, 0.98% increased risk of fractures, and 0.1% increased risk of upper gastrointestinal bleeding.

Metabolic Effects: There's an increased risk of developing diabetes mellitus with long-term antidepressant use, though the exact mechanisms aren't fully understood.

Hyponatremia: Low sodium levels in the blood can occur, particularly in older adults, potentially leading to confusion, weakness, and in severe cases, seizures or coma.

Sleep Disturbances: Chronic sleep problems, including multiple long-wake periods during the night, commonly develop with extended SSRI use.

Withdrawal and Discontinuation Challenges

Understanding Zoloft Withdrawal

When people decide to discontinue Zoloft after long-term use, they often encounter withdrawal symptoms that can be more severe and prolonged than initially expected. Zoloft withdrawal syndrome includes a wide range of physical and psychological symptoms that can significantly impact daily functioning.

Common withdrawal symptoms include:

  • Physical symptoms: dizziness, electric shock-like sensations, flu-like symptoms, nausea, headaches
  • Psychological symptoms: anxiety, irritability, mood swings, confusion
  • Sensory symptoms: visual disturbances, tinnitus, sensitivity to light and sound
  • Sleep-related symptoms: insomnia, vivid dreams, nightmares

It's crucial to understand that these withdrawal symptoms don't necessarily indicate a need for the medication, but rather reflect the brain's adjustment process as it adapts to functioning without the drug.

Factors Affecting Withdrawal Severity

Research has identified several key factors that influence the likelihood, severity, and duration of Zoloft withdrawal symptoms:

Duration of Use: This appears to be the strongest predictor of withdrawal severity. Studies show that for people who used antidepressants for less than 6 months, 64% experienced withdrawal effects of any severity. This number jumps to 86% for those using antidepressants for 7-24 months, and 96% for those using them for more than 24 months.

The severity also increases with longer use. People who used antidepressants for less than 6 months predominantly reported mild withdrawal symptoms, with only 7% experiencing severe effects. In contrast, those who used antidepressants for more than 24 months had much higher rates of severe withdrawal symptoms.

Individual Factors: Personal biology, genetics, previous withdrawal experiences, and overall health status all influence withdrawal severity. People who have experienced withdrawal symptoms when missing doses or during previous tapering attempts are more likely to experience significant withdrawal symptoms in the future.

Tapering Method: While the method of tapering (gradual dose reduction versus abrupt stopping) affects withdrawal severity, the duration of prior use remains the most important factor regardless of how carefully someone tapers.

Timeline and Duration Variability

One of the most important aspects of Zoloft withdrawal is its highly personalized nature. While some people only experience mild symptoms in the first few weeks , others may face prolonged withdrawal symptoms that can last months or even years.

Survey data reveals the wide range of withdrawal durations:

  • 15% experience withdrawal for 1 month or less
  • 19% experience symptoms for 3-6 months
  • 16% experience symptoms for 1-2 years
  • 19% experience symptoms for 2-5 years
  • 8% experience symptoms for more than 5 years

These prolonged symptoms, sometimes called Post-Acute Withdrawal Symptoms (PAWS), can persist long after the medication has been eliminated from the body. This occurs because the brain changes caused by chronic medication use can take much longer to reverse than the time needed for the drug itself to clear the system.

The Role of Proper Discontinuation Support

Given the complexities and potential challenges of long-term Zoloft use and withdrawal, specialized support becomes crucial for those considering discontinuation. The traditional medical approach of rapid tapering over 2-4 weeks often proves inadequate for people who have used antidepressants long-term.

Research supports much more gradual tapering approaches, sometimes extending over months or even years, with careful monitoring of withdrawal symptoms and adjustment of the tapering schedule based on individual response. This personalized approach recognizes that withdrawal is not a one-size-fits-all experience.

Outro Health represents a specialized approach to this challenge, offering personalized tapering plans developed by clinicians trained in evidence-based deprescribing methods. Their approach includes comprehensive withdrawal symptom monitoring, coordination with compounding pharmacies for precise dose reductions, and support for sustainable non-drug mental health practices during the transition period.

The clinical team at Outro understands the distinction between withdrawal symptoms and mental health relapse, helping people navigate the discontinuation process with appropriate medical support and avoiding unnecessarily prolonged medication use due to misinterpreted withdrawal symptoms.

Conclusion

Understanding the long-term side effects of Zoloft reveals a complex picture that extends far beyond the initial treatment period. From emotional blunting and cognitive changes to persistent sexual dysfunction and challenging withdrawal experiences, extended sertraline use can significantly impact multiple aspects of health and well-being.

The research clearly demonstrates that the longer someone takes Zoloft, the more likely they are to experience both side effects during treatment and withdrawal symptoms when discontinuing. However, individual experiences vary tremendously, and some people may use Zoloft long-term with minimal adverse effects while others may struggle with significant impacts on their quality of life.

Most importantly, anyone considering long-term Zoloft use or contemplating discontinuation should have access to comprehensive, evidence-based information and specialized medical support. The decision to continue or discontinue any medication should always involve careful consideration of individual circumstances, potential benefits, risks, and personal treatment goals in consultation with knowledgeable healthcare providers.

For those experiencing long-term effects or considering tapering, remember that support is available and that many people successfully navigate the transition off antidepressants with proper guidance and patience with the process.

If you're considering tapering off Zoloft or other antidepressants, Outro Health offers specialized support through evidence-based, personalized tapering programs. Our clinical team, co-founded by leading deprescribing expert Dr. Mark Horowitz, provides comprehensive withdrawal monitoring, custom taper plans, and coordinated care to help you safely navigate the discontinuation process. Learn more about how Outro can support your journey toward medication-free wellness.

References

Bet, P. M., Hugtenburg, J. G., Penninx, B. W., & Hoogendijk, W. J. (2013). Side effects of antidepressants during long-term use in a naturalistic setting. European Neuropsychopharmacology, 23(11), 1443-1451.
Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016). Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Preference and Adherence, 10, 1401-1407.
European Medicines Agency. (2019). New product information wording – extracts from PRAC recommendations on signals. Retrieved from https://www.ema.europa.eu/en/documents/other/new-product-information
Gafoor, R., Booth, H. P., & Gulliford, M. C. (2018). Antidepressant utilisation and incidence of weight gain during 10 years' follow-up: population based cohort study. BMJ, 361, k1951.
Goodwin, G. M., Price, J., De Bodinat, C., & Laredo, J. (2017). Emotional blunting with antidepressant treatments: a survey among depressed patients. Journal of Affective Disorders, 221, 31-35.
Healy, D., Le Noury, J., & Mangin, D. (2018). Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. International Journal of Risk & Safety in Medicine, 29(3-4), 125-134.
Hindmarch, I. (2009). Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder. International Journal of Clinical Practice, 63(7), 1085-1094.
Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-546.
Horowitz, M. A., Wilcock, M., Kalra, M. K., & Cope, T. (2025). Duration of antidepressant use predicts the likelihood and severity of withdrawal syndrome: systematic analysis of patient survey data. Psychiatry Research, 343, 115985.
Langley, C., Armand, S., Luo, Q., Savulich, G., Segerberg, T., Søndergaard, A., ... & Sahakian, B. J. (2023). Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study. Neuropsychopharmacology, 48(4), 664-670.
Ma, H., Cai, M., & Wang, H. (2021). Emotional blunting in patients with major depressive disorder: a brief non-systematic review of current research. Frontiers in Psychiatry, 12, 792960.
Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023). The serotonin theory of depression: a systematic umbrella review of the evidence. Molecular Psychiatry, 28(8), 3243-3256.
Read, J., & Williams, J. (2018). Adverse effects of antidepressants reported by a large international cohort: emotional blunting, suicidality, and withdrawal effects. Current Drug Safety, 13(3), 176-186.
Reisman, Y. (2020). Post-SSRI sexual dysfunction. BMJ, 368, m754.
Sansone, R. A., & Sansone, L. A. (2010). SSRI-induced indifference. Psychiatry, 7(10), 14-18.
Sayyah, M., Eslami, K., AlaiShehni, S., & Kouti, L. (2016). Cognitive function before and during treatment with selective serotonin reuptake inhibitors in patients with depression or obsessive-compulsive disorder. Psychiatry Journal, 2016, 5480391.

Build your personalized tapering plan
Get Started

Related posts

Discover more articles related to stopping antidepressants.

Curious if you could stop your antidepressant?

Outro is now accepting patients in several states and actively expanding. If you don't see your state here, join the waitlist via the onboarding flow.